The order of immunological parameter priority was suggested since highly specific mimotopes would have higher performance in MHC class II restriction rather than MHC class I restriction due to the potential for long term memory immune responses between MHC class II molecules with Th cells when used against a specific cancer subtype. Here, HLA-C is linked to cancer.